Genworth's Enact Cash Engine Faces A Test From Hotter Long-Term Care Losses

Genworth heads into its third-quarter report with two stories pulling in opposite directions. Its mortgage insurance subsidiary, Enact, keeps sending more cash upstream, and management responded last quarter by raising buyback guidance for the second time this year. Meanwhile, the legacy long-term care block is losing more money than planned, the CareScout growth effort is missing its match target, and the chief executive is on medical leave. The November 4 release, due after the close, will show which of these stories carries more weight.

The headline numbers offer little help. Genworth earned a penny per share last quarter on $1.90 billion in revenue, compared with $0.04 on $1.94 billion in the year-ago third quarter. Those thin figures reflect closed-block losses swamping Enact's steady contribution. A usable consensus picture is hard to establish, so the more meaningful benchmarks are the operating targets management has already set.

Enact is the clearest of those benchmarks. Last quarter it raised its expected 2026 capital return to roughly $550 million to $600 million, up from about $500 million. That lifted Genworth's expected share to $445 million to $485 million, and Genworth in turn raised its own repurchase target to $225 million to $250 million. Enact's adjusted operating income to Genworth was $143 million, new insurance written reached $15 billion, and capital sat about $1.9 billion above regulatory requirements. A similar contribution in the third quarter, along with buyback activity on pace for the upper part of the new range, would confirm that the capital return thesis is intact. Any slippage in Enact's earnings or a slower repurchase cadence would matter more than usual, because the stock's appeal now rests heavily on that cash stream.

The closed block is the main risk. Actual-versus-expected losses in long-term care reached $127 million pretax in the second quarter, producing a $110 million operating loss for the block. Management warned that full-year losses could exceed the roughly $300 million it had reaffirmed twice before. These are largely non-cash accounting hits, but another heavy quarter would suggest claims experience is getting worse rather than reverting. A meaningful improvement would ease one of the bigger worries that has built up since summer.

CareScout needs to regain momentum. Matches in the first half more than doubled to about 2,950, but management said the pace was running below what is needed to reach 7,500 for the full year. That was a softer message than the on-track language used a quarter earlier. Services revenue has held flat at about $6 million a quarter against a $25 million annual target, which implies a step-up in the back half. The Worksite long-term care product was slated to launch in the third quarter in at least 34 states, so early commentary on its rollout and on the senior living network expansion will show whether this effort can stand on its own. Investors will also want an update on the AXA appeal. The hearing took place in July, a decision was expected within three to six months, and a ruling could deliver roughly $750 million tax-free.

The market has turned skeptical. Shares fell 8.9% since the last report while the S&P 500 was flat. At $8.89, the stock trades below its 200-day average of $9.10 and close to the $8.68 low of its post-earnings range. Bearish sentiment has deepened noticeably from a quarter ago. That lowers the bar somewhat, but the central question is unchanged. If Enact's growing distributions keep outpacing the drag from long-term care losses and leadership uncertainty, the capital return story survives. If the closed block deteriorates again, the buyback narrative will be harder to sell.

This earnings preview was originally published on Earnings Whispers.

This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.